A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors
A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors
Recruiting · NCT05957536 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors | HER-2 Positive Advanced Solid Tumors | Recruiting | Phase 1 | 2026-08-28 | NCT05957536 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| D3 Bio (Wuxi) Co., Ltd | 5 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||